OriGene Technologies Revenue and Competitors

Claim your profile

Location

$69.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • OriGene Technologies's estimated annual revenue is currently $17.8M per year.(i)
  • OriGene Technologies received $0.2M in venture funding in March 2014.
  • OriGene Technologies's estimated revenue per employee is $155,000
  • OriGene Technologies's total funding is $69.4M.

Employee Data

  • OriGene Technologies has 115 Employees.(i)
  • OriGene Technologies grew their employee count by -3% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.2M40-2%$17.5MN/A
#2
$15.7M101-7%$10.5MN/A
#3
$17.8M115-3%$69.4MN/A
#4
$2M1344%$40MN/A
#5
$5.6M36N/AN/AN/A
#6
$1.4M9-31%N/AN/A
#7
$2.8M18N/A$34.7MN/A
#8
$2.6M17N/AN/AN/A
#9
$1.7M1122%N/AN/A
#10
$2M1344%$10.6MN/A

OriGene Technologies was founded as a research tool company focused on the creation of the largest commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based tools have enabled the identification of relevant drug targets through system biology approaches. OriGene's vision is to prepare comprehensive, genome wide research tools and technology platforms to enable scientists to study complete biological pathways, thus enabling a better understanding of disease mechanisms including cancer and stem cell research. OriGene Technologies uses high-throughput, genome wide approach to develop products for pharmaceutical, biotechnology, and academic research. Our flagship product is the cDNA clone collection, a searchable gene bank of over 30,000 human full-length TrueClone cDNA collection and over 25,000 TrueORF cDNA clones. From our TrueORF cDNA clones, we have developed the largest offering of full length human proteins expressed in mammalian cells, ideal for functional studies. In 2010, OriGene initiated the TrueMAB project to develop mouse monoclonal antibodies against protein antigens with the goal to develop protein assays for every human protein. In addition, OriGene offers unique gene expression products such as TissueScan cancer tissue qPCR arrays and tissue biorepository for biomarker discovery and validation OriGene is committed to its mission to be Your Gene Company, in supplying everything a researcher needs for gene based research.

keywords:Biotechnology,E-Commerce,Healthcare,Software Development

$69.4M

Total Funding

115

Number of Employees

$17.8M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

OriGene Technologies News

2013-03-22 - Genomics research supplier rounds up $21.3 million from China-focused investors

Among OriGene’s offerings is a searchable collection of full-length human cDNA clones and a line of ultra-specific monoclonal antibodies called UltraMAB used by pharmaceutical companies and scientists to study complete biological pathways. The Rockville, Maryland, company was founded by Dr. Wei ...

2015-07-07 - OriGene Technologies Receives Investment

OriGene Technologies, a Rockville, MD-based life science company producing biotechnology products for the research and medical markets, recently received an investment of undisclosed amount. Backers included Cathay Capital Private Equity, which made the investment through the Sino French Fund f ...

2015-10-28 - OriGene Technologies Acquires Acris Antibodies

OriGene Technologies, Inc., a Rockville, MD-based developer of genome wide products for research and diagnostic applications, acquired Acris Antibodies GmbH, a Herford, Germany and San Diego, CA-based provider of antibodies and other life science related products. The amount of the deal was not ...

09/09/2019 - Global Genome Editing Market Insights 2019-2026: Merck ...

Global Genome Editing Market Insights 2019-2026: Merck & Co., Bio-Rad Laboratories, Inc., Origene Technologies, Transposagen.

09/04/2019 - Fusion Protein Market – Abnova Corporation, Novus ...

Fusion Protein Market – Abnova Corporation, Novus Biologicals, OriGene Technologies, Inc., Thermo Fisher Scientific Inc., PeproTech, Inc., ...

08/28/2019 - Gene Synthesis Market : Key Players are Genewiz, Eurofins ...

Gene Synthesis Market : Key Players are Genewiz, Eurofins Scientific, ATD Bio Ltd., OriGene Technologies, Inc., Bioneer Corporation, Atum, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.8M1181%N/A
#2
$17.3M11924%N/A
#3
$17.4M1205%N/A
#4
$17.5M121-3%N/A
#5
$18.6M1242%N/A

OriGene Technologies Funding

DateAmountRoundLead InvestorsReference
2004-04-21$0.1MUndisclosedASM ResourcesArticle
2004-05-11$2.3MAEmerging Technology PartnersArticle
2010-03-18$16.0MBDG-Accel, SBI & TH Venture Capital EnterArticle
2013-03-22$21.3MCQiming Venture PartnersArticle
2014-03-12$0.2MUndisclosedArticle